Windlas Biotech Limited has informed the Exchange regarding Change in Auditors of the company.
WINDLAS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Windlas Biotech's board approved two auditor appointments on May 22, 2025. M/s J C Bhalla & Co (Firm Registration No. 001111N) will take over as the new Statutory Auditor for a 5-year term, from the conclusion of the 24th AGM until the AGM in 2030. The previous statutory auditor, M/s SS Kothari Mehta & Co LLP, is exiting because its term is expiring naturally at the upcoming AGM — this is a routine rotation, not a premature exit. Additionally, M/s Sandeep Joshi & Associates has been appointed as the new Secretarial Auditor for five years covering FY 2025-26 to FY 2029-30. Both appointments need shareholder approval at the next AGM. J C Bhalla & Co is a long-established firm founded in 1943 with significant experience auditing manufacturing companies.
This is a standard end-of-term auditor rotation, not driven by any governance concerns or disputes. The incoming statutory auditor is a well-reputed, 80-year-old firm, which should reassure investors. No material impact on the stock is expected from this filing.